Papachristou DN, Agnanti N, D’Agostino H, Fortner JG. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 1980; 139: 711-713.
Hockey MS, Fielding JWL, Kelly KA, et al. for the British Stomach Cancer Group. Resection line disease in stomach cancer. Br Med J 1984; 289: 601-603.
Songun I, Bonenkamp JJ, Hermans J, et al. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32A: 433-437.
Kim SH, Karpeh MS, Klimstra DS, Leang D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 1999; 3: 2433.
Cascinu S, Giordani P, Catalano V, Agostinelli R, Catalano G. Resection-line involvement in gastric cancer patients undergoing curative resections: Implications for clinical management. Jap J Clin Oncol 1999; 29: 291-293.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma -2nd English edition-. Gastric Cancer 1998; 1: 10-24.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
White RR, Mackie JA, Fitts WT. An analysis of twenty years’ experience with operations for carcinoma of the stomach. Ann Surg 1975; 181: 611-614.
Schrock TR, Way LW. Total gastrectomy. Am J Surg 1978; 135: 348-355.
Bizer LS. Adenocarcinoma of the stomach. Current results of treatment. Cancer 1983; 51: 743-745.
Blomjous JGAM, Hop WCJ, Langenhorst LAM, ten Kate FJW, Eykenboom WMH, Tilanus HW. Adenocarcinoma of the gastric cardia: Recurrence and survival after resection. Cancer 1992; 70: 569-574.
Hallissey MT, Jewkes AJ, Dunn JA, Fielding JWL. Resection-line involvement in gastric cancer: A continuing problem. Br J Surg 1993; 80: 1418-1420.
Chan WH, Wong WK, Khin LW, Chan HS, Soo KC. Significance of a positive oesophageal margin in stomach cancer. Aust NZJ Surg 2000; 70: 700-703.
Ersan Y, Yavuz N, Kuflaslan R, ve ark. Potansiyel olarak küratif rezeksiyon geçiren mide kanseri hastalar›nda mikroskopik rezeksiyon s›n›r› tutulmas›n›n erken ve geç sonuçlar›. Cerrahpafla T›p Dergisi 2005; 36: 12-19.
Zacho A, Cederqvist C, Fischerman K. Surgical treatment of gastric malignancies: A twenty-year series comprising mainly far advanced and high-seated tumors. Ann Surg 1974; 179: 94-101.
Kim J-P, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216: 269-278.
Smith JW, Brennan MF. Surgical treatment of gastric cancer. Surg Clin N Am 1992; 72: 381-399.
Munson JL, O’Mahony R. Radical gastrectomy for cancer of the stomach. Surg Clin N Am 2005; 85: 1021-1032.
Bozzetti F, Bonfanti G, Bufalino R, et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 1982; 196: 685-690.
Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 1997; 226: 613-620.
Keighley MRB, Moore J, Lee JR, Malins D, Thompson H. Peroperative frozen section and cytology to assess proximal invasion in gastro-oesophageal carcinoma. Br J Surg 1981; 68: 73-74.
Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma: Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992; 70: 1030-1037.
Tsujitani S, Okuyama T, Orita H, et al. Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 1995; 42: 873-877.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of stomach: A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-592.
Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36: 7-12.
Sano T, Mudan SS. No advantage of reoperation for positive resection margins in node positive gastric cancer patients? Jap J Clin Oncol 1999; 29: 283-284.
Papachristou DN, Agnanti N, D’Agostino H, Fortner JG. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 1980; 139: 711-713.
Hockey MS, Fielding JWL, Kelly KA, et al. for the British Stomach Cancer Group. Resection line disease in stomach cancer. Br Med J 1984; 289: 601-603.
Songun I, Bonenkamp JJ, Hermans J, et al. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32A: 433-437.
Kim SH, Karpeh MS, Klimstra DS, Leang D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 1999; 3: 2433.
Cascinu S, Giordani P, Catalano V, Agostinelli R, Catalano G. Resection-line involvement in gastric cancer patients undergoing curative resections: Implications for clinical management. Jap J Clin Oncol 1999; 29: 291-293.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma -2nd English edition-. Gastric Cancer 1998; 1: 10-24.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
White RR, Mackie JA, Fitts WT. An analysis of twenty years’ experience with operations for carcinoma of the stomach. Ann Surg 1975; 181: 611-614.
Schrock TR, Way LW. Total gastrectomy. Am J Surg 1978; 135: 348-355.
Bizer LS. Adenocarcinoma of the stomach. Current results of treatment. Cancer 1983; 51: 743-745.
Blomjous JGAM, Hop WCJ, Langenhorst LAM, ten Kate FJW, Eykenboom WMH, Tilanus HW. Adenocarcinoma of the gastric cardia: Recurrence and survival after resection. Cancer 1992; 70: 569-574.
Hallissey MT, Jewkes AJ, Dunn JA, Fielding JWL. Resection-line involvement in gastric cancer: A continuing problem. Br J Surg 1993; 80: 1418-1420.
Chan WH, Wong WK, Khin LW, Chan HS, Soo KC. Significance of a positive oesophageal margin in stomach cancer. Aust NZJ Surg 2000; 70: 700-703.
Ersan Y, Yavuz N, Kuflaslan R, ve ark. Potansiyel olarak küratif rezeksiyon geçiren mide kanseri hastalar›nda mikroskopik rezeksiyon s›n›r› tutulmas›n›n erken ve geç sonuçlar›. Cerrahpafla T›p Dergisi 2005; 36: 12-19.
Zacho A, Cederqvist C, Fischerman K. Surgical treatment of gastric malignancies: A twenty-year series comprising mainly far advanced and high-seated tumors. Ann Surg 1974; 179: 94-101.
Kim J-P, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216: 269-278.
Smith JW, Brennan MF. Surgical treatment of gastric cancer. Surg Clin N Am 1992; 72: 381-399.
Munson JL, O’Mahony R. Radical gastrectomy for cancer of the stomach. Surg Clin N Am 2005; 85: 1021-1032.
Bozzetti F, Bonfanti G, Bufalino R, et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 1982; 196: 685-690.
Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 1997; 226: 613-620.
Keighley MRB, Moore J, Lee JR, Malins D, Thompson H. Peroperative frozen section and cytology to assess proximal invasion in gastro-oesophageal carcinoma. Br J Surg 1981; 68: 73-74.
Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma: Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992; 70: 1030-1037.
Tsujitani S, Okuyama T, Orita H, et al. Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 1995; 42: 873-877.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of stomach: A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-592.
Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36: 7-12.
Sano T, Mudan SS. No advantage of reoperation for positive resection margins in node positive gastric cancer patients? Jap J Clin Oncol 1999; 29: 283-284.